Multi-mechanistic accommodating intraocular lenses

Information

  • Patent Grant
  • 7150759
  • Patent Number
    7,150,759
  • Date Filed
    Friday, September 12, 2003
    21 years ago
  • Date Issued
    Tuesday, December 19, 2006
    18 years ago
Abstract
An intraocular lens (IOL) includes an optic for focusing light and an accommodation assembly for axially moving and/or deforming the optic in response to naturally occurring actions of the eye, thus allowing a patient to more effectively focus on near objects. In addition, the optic may be multifocal or aspheric, wherein the maximum add power of the lens is combined with the increase in diopter power obtained through axial movement and/or deformation of the optic, resulting in enhanced accommodation.
Description
BACKGROUND OF THE INVENTION

The present invention relates to intraocular lenses (IOLs). More particularly, the present invention relates to IOLs that provide accommodating movement in the eye.


The human visual system includes the eyes, the extraocular muscles which control eye position within the eye socket, the optic and other nerves that connect the eyes to the brain, and particular areas of the brain that are in neural communication with the eyes. Each eye forms an image upon a vast array of light sensitive photoreceptors of the retina. The cornea is the primary refracting surface which admits light through the anterior part of the outer surface of the eye. The iris contains muscles which alter the size of the entrance port of the eye, or pupil. The crystalline lens has a variable shape within the capsular bag, under the indirect control of the ciliary muscle. Having a refractive index higher than the surrounding media, the crystalline lens gives the eye a variable focal length, allowing accommodation to objects at varying distances from the eye.


Much of the remainder of the eye is filled with fluids and materials under pressure which help the eye maintain its shape. For example, the aqueous humor fills the anterior chamber between the cornea and the iris, and the vitreous humor fills the majority of the volume of the eye in the vitreous chamber behind the lens. The crystalline lens is contained within a third chamber of the eye, the posterior chamber, which is positioned between the anterior and vitreous chambers.


The human eye is susceptible to numerous disorders and diseases, a number of which attack the crystalline lens. For example, cataracts mar vision through cloudy or opaque discoloration of the lens of the eye. Cataracts often result in partial or complete blindness. If this is the case, the crystalline lens can be removed and replaced with an intraocular lens, or IOL.


While restoring vision, conventional IOLs have limited ability for accommodation (i.e., the focusing on near objects). This condition is known as presbyopia. To overcome presbyopia of an IOL, a patient may be prescribed eyeglasses. Alternative attempts in the art to overcome presbyopia focus on providing IOLs with accommodation ability. Accommodation may be accomplished by either changing the shape of the IOL, e.g., to become more convex to focus on near objects, or by moving the IOL along its optical axis.


IOLs which achieve accommodation by changing shape generally fall into one of two categories. In the first category, external means, such as magnetic or electric fields, inflation devices, or micromotors, are used to change the curvature of a deformable optic. In the second category, a force transfer assembly is provided for transferring the natural forces exerted by the eye to a composite optic including two or more portions with differing mechanical and/or optical properties.


Examples of the first category (i.e. externally actuated) shape-changing accommodating IOLs are found in Schachar U.S. Pat. No. 4,373,218, Kern U.S. Pat. No. 4,601,545, Pfoff U.S. Pat. No. 4,816,031, Wiley U.S. Pat. Nos. 5,066,301, 5,108,429, and 5,203,788, and Wiley et al. U.S. Pat. No. 5,171,266. The disclosures of each of these patents are incorporated herein in their entireties by reference.


Examples of the second category of shape-changing (i.e. naturally actuated) accommodating IOLs are found in Sulc et al. U.S. Pat. No. 4,994,083 and Turley U.S. Pat. No. 4,892,543. The disclosures of each of these patents are incorporated herein in their entirety by reference. Other examples of naturally actuated, shape-changing accommodating IOLs are described in co-pending, commonly assigned U.S. patent application Ser. Nos. 09/656,661, 09/657,251, and 09/657,325, all filed on Sep. 7, 2000, and in co-pending, commonly assigned U.S. patent application Ser. No. 09/855,331, filed May 15, 2001. The disclosures of each of these applications are incorporated herein in their entirety by reference.


Examples of axially movable accommodating IOLs are disclosed in Gwon et al. U.S. Pat. No. 6,176,878 and Laguette et al. U.S. Pat. No. 6,406,494. The disclosures of both these patents are incorporated herein in their entirety by reference.


IOLs which use primarily only one of the above mechanisms for accommodation have not been able to achieve the full add power required for a typical patient.


In view of the foregoing, it would be beneficial in the art, and there continues to be a need, to provide new IOLs with enhanced accommodation ability.


SUMMARY OF THE INVENTION

In accordance with the present invention, various arrangements are provided for providing IOLs with enhanced accommodation ability. The accommodation may be achieved solely through axial movement of the optic, or through a combination of one or more of axial movement, deformation, and multifocal design of the optic.


In a first broad aspect of the invention, an intraocular lens comprises a unitary optic formed of a deformable material, and an accommodation assembly coupled to the optic and structured to cooperate with the eye to effect accommodating axial movement of the optic and accommodating deformation of the optic in response to one or more naturally occurring actions of the eye. The combined axial movement and deformation is effective to provide enhanced accommodation relative to the axial movement alone or the deformation alone.


In one advantageous embodiment of the invention, the optic is an aspheric optic having progressive correction powers that vary from a baseline power for distance vision correction to an add power that is reduced relative to a power for full near vision correction, wherein the combined axial movement, deformation, and add power is effective to provide enhanced accommodation relative to the axial movement and the deformation without the add power.


In another advantageous embodiment of the invention, the optic is a multifocal optic having a first zone configured to provide distance vision correction and a second zone having an add power that is reduced relative to a power for full near vision correction, wherein the combined axial movement, deformation, and add power is effective to provide enhanced accommodation relative to the axial movement and the deformation without the add power.


In a second broad aspect of the invention, an intraocular lens comprises a unitary, deformable multifocal optic including a first zone having a baseline power for distance vision correction and a second zone having an add power, and a force transfer assembly coupled to the optic and structured to cooperate with the eye to effect deformation of the optic so as to change the power of at least one of the first and second zones. Preferably, the force transfer assembly is structured to increase the curvature of at least one of the zones in response to a compressive force exerted by the eye, thereby increasing the power of that zone. More preferably still, the force transfer assembly is also structured to axially move the optic in responsive to the compressive force exerted by the optic, wherein the axial movement of the optic combines with the increased add power obtained through the deformation to provide enhanced accommodation relative to the deformation alone.


In a third broad aspect of the invention, an intraocular lens comprises a deformable optic having progressive correction powers that vary from a baseline power for distance vision correction to a maximum add power that is reduced relative to a power for full near vision correction, and a force transfer assembly coupled to the optic and structured to cooperate with the eye to effect deformation of the optic so as to increase the maximum add power. Preferably, the force transfer assembly is also structured to axially move the optic in responsive to the compressive force exerted by the optic, wherein the axial movement of the optic combines with the increased add power obtained through the deformation to provide enhanced accommodation relative to the deformation alone. More preferably, the force transfer assembly is also structured to axially move the optic in responsive to the compressive force exerted by the optic, wherein the axial movement of the optic combines with the increased add power obtained through the deformation to provide enhanced accommodation relative to the deformation alone.


A preferred embodiment of the movement/force transfer assembly usable with the invention according to any of all of the above broad aspects comprises an outer ring surrounding the optic, and movement assembly including a plurality of intermediate members that extend between the optic and the outer ring and transmit forces therebetween. The optic preferably has a circular periphery centered on an optical axis and is adapted to focus light toward a retina of an eye and to provide a vision correction. The outer ring is spaced from the optic with voids therebetween.


The outer ring may be either circular or ovoid in configuration. In embodiments having a circular outer ring, the intermediate members are preferably distributed asymmetrically about any plane that includes the optical axis. For instance, in one preferred embodiment, three intermediate members are arranged at 120° intervals around the circumference of the ring. In embodiments having an oval outer ring, there are preferably only two diametrically opposed intermediate members.


In the case of an oval outer ring, the ring has a major axis and a minor axis. In one embodiment of the invention, the outer end of each intermediate member is secured to the outer ring at a point on the major axis, and the inner end is secured to the periphery of the optic at a point on the minor axis. In other words, the intermediate members are non-linear, and the inner and outer ends are displaced by 90° with respect to one another. In another embodiment, the inner and outer ends are both aligned with the major axis.


Each intermediate member may have a hinge therein that permits radial forces imparted by the surrounding eye structure, e.g. muscles, to more effectively translate the optic along the optical axis. The hinges may have any suitable structure effective to provide such enhanced translation relative to a substantially identical IOL including intermediate members without hinges, such as an IOL with uniformly structured intermediate members. A typical hinge structure may include a reduced axial or circumferential thickness region along a plate-like intermediate member.


Preferably, the outer ring has an outer surface that is convexly outwardly curved to match the contour of the interface between the capsular bag and the zonules of the eye. In addition, the outer ring may have at least one relatively sharp edge to reduce epithelial cell growth thereon. In addition, the outer ring may be continuous and have an axial thickness of at least 0.4 mm. Desirably, the optic, outer ring and intermediate members are integrally formed, for example molded, of a single piece of material.


In one embodiment, the outer ring has an axial dimension and the intermediate members attach to a posterior edge of the outer ring. Furthermore, the intermediate members may be bowed in the posterior direction, causing the optic to be posteriorly vaulted.


Each and every feature described herein, and each and every combination of two or more of such features, is included within the scope of the present invention provided that the features included in such a combination are not mutually inconsistent.


Additional aspects, features, and advantages of the present invention are set forth in the following description and claims, particularly when considered in conjunction with the accompanying drawings in which like parts bear like reference numbers.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a vertical cross-section of an eye illustrating an exemplary intraocular lens of the present invention positioned within the capsular bag;



FIG. 2 is a cross-section similar to FIG. 1 showing forward or anterior movement of an optic of the intraocular lens;



FIG. 3 is a plan view of the exemplary intraocular lens of the present invention having an oval outer ring and a pair of nonlinear intermediate members;



FIG. 4 is a plan view of an alternative intraocular lens of the present invention having two radially oriented intermediate members;



FIG. 5 is a plan view of an alternative intraocular lens of the present invention having three radially oriented intermediate members;



FIG. 6 is a perspective view of an alternative intraocular lens of the present invention having three radially oriented intermediate members;



FIG. 6A is an elevational view of one edge of the intraocular lens of FIG. 6;



FIG. 7A is a perspective posterior view of a still further alternative intraocular lens of the present invention having three radially oriented plate-like intermediate members and an optic that is bowed slightly out of the plane of a surrounding capsular bag support ring;



FIG. 7B is a perspective anterior view of the intraocular lens of FIG. 7A;



FIGS. 7C and 7D are plan and side elevational views, respectively, of the intraocular lens of FIG. 7A;



FIG. 7E is a sectional view taken through line 7E—7E of FIG. 7B;



FIG. 8A is a perspective view of a still further alternative intraocular lens of the present invention having two radially oriented plate-like intermediate members connecting a central optic to an oval surrounding capsular bag support ring;



FIG. 8B is another perspective view of the intraocular lens of FIG. 8A; and



FIGS. 8C and 8D are side elevational and plan views, respectively, of the intraocular lens of FIG. 8A.



FIG. 9 is a view similar to FIG. 7B, showing an embodiment of the invention having an alternate hinge configuration;



FIG. 10A is an anterior plan view showing yet another embodiment of an intraocular lens according to the present invention;



FIG. 10B is a sectional view taken through line B—B of FIG. 10A; and



FIG. 10C is a sectional view taken through line C—C of FIG. 10A;



FIGS. 11 and 12 are side elevational views of an equiconvex optic.





DESCRIPTION OF THE PREFERRED EMBODIMENTS

Referring to the drawings in more detail, an intraocular lens (IOL) 20 according to an exemplary embodiment of the present invention is illustrated in FIGS. 1 and 2 after implantation in the capsular bag 22 of an eye. Exemplary IOL 20 includes an optic 24 and a movement assembly 26 coupled thereto. The optic 24, which has an optical axis OA, is adapted to focus light onto a retina of an eye. The movement assembly 26 of exemplary IOL 20 cooperates with the eye to effect accommodating movement of the optic 24 and, in particular, converts radial movement (i.e., movement perpendicular to the optical axis OA) of the capsular bag of an eye to axial movement (i.e., movement parallel to the optical axis OA) of the optic 24. In the exemplary embodiment, the movement assembly 26 biases the optic 24 in a posterior direction (to the right) against the posterior wall of the capsular bag 22.


A brief description of the anatomy of the eye is appropriate in order to understand the invention. The capsular bag 22 resides in the posterior chamber of the eye and is in direct contact with the jelly-like vitreous humor 28 which fills the nearly spherical space between the capsular bag and the retina (not shown). In a healthy person, the capsular bag 22 contains the natural crystalline lens which transmits light passing through the orifice of the iris 30 to the retina. The capsular bag 22 is connected to an annular ciliary muscle 34 by suspensory ligaments or zonules 36. The ciliary muscle 34 is the chief agent in accommodation, i.e., in adjusting the eye to focus on near objects. The zonules 36 retain the lens in position and are relaxed by the contraction of the ciliary muscle 34, thereby allowing a natural crystalline lens to become more convex.


Applying this anatomy to the present invention, exemplary IOL 20 is configured to facilitate movement of the optic 24 in response to the action of the ciliary muscle 34 and the zonules 36. When the ciliary muscle 34 constricts inward, the zonules 36 relax and reduce the equatorial diameter of the capsular bag 22, wherein the optic 24 translates in the posterior direction against the rear wall of the capsular bag 22. Conversely, when the ciliary muscle 34 relaxes, the zonules 36 tense and increase the equatorial diameter of the capsular bag 22, thereby moving the optic 24 in the anterior direction, or at least reducing the posterior bias.


It should be understood that, in the illustrated embodiment, the optic 24 is biased against the rear wall of the capsular bag 22 at all times, and axial movement of the optic from the action of the ciliary muscle 34 is primarily governed by the position of the rear wall. That is, changes in pressure of the vitreous humor 28 act on the rear wall of the capsular bag 22 and cause it to translate in the axial direction. This movement is facilitated by relaxation of the ciliary muscle 34, which at least reduces the rearward bias of the optic 24. For example, FIG. 2 illustrates forward movement of the optic 24 due to increase in pressure of the vitreous humor 28. One advantage of the present invention is that the optic 24 remains biased against the rear wall of the capsular bag 22 yet can accommodate substantial forward or anterior movement because of long intermediate members.



FIG. 3 illustrates the exemplary IOL 20 in plan view, wherein a generally circular periphery or peripheral edge 42 defines the radially outer extent of the optic 24 and separates a posterior face from an anterior face. The optic 24 is typically circular, but may exhibit a different shape as long as the optical correction character is centered about the optical axis OA. The optic 24 may be bi-convex, or the anterior and posterior faces can take other shapes, such as planar or concave. In any event, the posterior face and anterior face are spaced apart on opposite sides of an optic plane (not shown) that extends perpendicular to the optical axis OA. In other words, the optic 24 is centered on and oriented in the optic plane.


In a preferred embodiment, the optic 24 is a multifocal optic having a plurality of zones of varying optical powers, wherein the maximum add power of the Anear zones is reduced by an amount equivalent to the diopter shift obtained through axial movement of the optic 24. Thus, the net power correction in the near zones is equal to the patients full add prescription only when optic 24 has moved to the near distance (i.e. anteriormost) position. Examples of suitable multifocal optics are disclosed in Lang et al. U.S. Pat. No. 6,231,603 and Lang et al. PCT International Application No. WO/01/82839 A1. The disclosures of both the U.S. patent and this PCT international application are incorporated in their entireties herein by reference.


The movement assembly 26 comprises a pair of intermediate members 50a, 50b connected to and extending between the circular periphery 42 of the optic 24 and an outer ring 52. Each intermediate member 50a, 50b has an inner end 54 connected to the circular periphery 42, and an outer end 56 connected to the outer ring 52. AConnected in this sense means firmly attached to with adhesive or ultrasonic bonding, or preferably formed integrally, or as a cohesive single piece. In the latter case, the lens is desirably molded. Each intermediate member 50a, 50b is desirably oriented in a plane that is in the optic plane. Indeed, the intermediate members 50a, 50b and outer ring 52 may have approximately the same thickness and be located in the same plane.


Although controlled fibrosis (i.e., cellular growth) on the outer ring 52 may be desirable, the IOLs 20 of the invention inhibit cell growth, particularly epithelial cell growth, onto the optic 24. This is accomplished by configuring the periphery 42 of the optic 24 with mechanical barriers such as relatively sharp posterior and/or anterior edge corners. The proliferation of unwanted epithelial cell growth may also be inhibited through the use of material properties.


The intermediate members 50a, 50b of the IOL 20 are substantially longer than previous intermediate members as they extend in a nonlinear fashion from the outer ring 52 to the circular optic periphery 42. More particularly, the inner end 54 and outer end 56 are angularly spaced about the optical axis OA by at least approximately 90°. The mid-portion of each intermediate member 50 extends in a serpentine fashion between its inner and outer ends.


In a preferred embodiment, as seen in FIG. 3, the outer ring 52 is oval in shape and has a major axis 60 perpendicular to the optical axis OA. A minor axis 62 extends perpendicularly to the major axis 60 and to the optical axis OA. Desirably, the outer ends 56 of the intermediate members 50 connect to the oval ring 52 along the major axis 60. In this way, the length of the intermediate members 50 is maximized. In the illustrated embodiment, the inner ends 54 of the intermediate members 50 connect to the circular optic periphery 42 along the minor axis 62. Therefore, the inner and outer ends 54, 56 are angularly spaced apart by about 90°.



FIG. 4 illustrates an alternative IOL 70 of the present invention having an optic 72, an oval outer ring 74, and a pair of intermediate members 76a, 76b extending radially therebetween. Again, the optic 72, outer ring 74 and intermediate members 76a, 76b are desirably formed as a single homogeneous (i.e., integral) piece. The oval outer ring 74 is believed to move the optic 72 axially with greater effectiveness than a circular ring because of the orientation of the intermediate members 76a,b along the major axis.


The fixation members 76a,b are shown as plate-like, and desirably are greater in width (the dimension parallel to the minor axis) than axial thickness (the dimension parallel to the optical axis). Preferably, the ratio of width to axial thickness is about four. In absolute terms, the width of the fixation members 76a, 76b may be between about 0.8 mm and about 3.0 mm.



FIG. 5 illustrates a still further IOL 80 having an optic 82, an outer ring 84, and three evenly arranged and radially oriented intermediate members 86a, 86b and 86c. Because the intermediate members 86 are not symmetric about any plane through the optical axis OA, forces exerted by the surrounding capsular bag do not act in opposition to one another and thus are translated more effectively into axial movement of the optic 82. The radial thickness tr of the outer ring 84 is indicated, and is desirably in the range of 0.2–0.6 mm. Moreover, the corners, or at least one corner, of the outer peripheral edge of the outer ring 84 are desirably relatively sharp to reduce the instance of epithelial cell growth thereon.



FIGS. 6 and 6A illustrate a still further IOL 90 having an optic 92, a plurality of intermediate members 94 extending radially outward therefrom, and an outer ring 96. The edge surface 97 of the outer ring 96 may be contoured to conform to the inner wall of the capsular bag. Therefore, as seen in FIG. 6A, at least a portion 98 of the edge surface 97 is convexly outwardly curved. At the same time, at least one corner, in this case the posterior corner 99, is left sharp (i.e. unpolished) to form a barrier against posterior capsular opacification (PCO).


Furthermore, FIG. 6 illustrates the greater axial thickness ta of the outer ring 96 with respect to the axial thickness of the intermediate members 94 and optic 92. Specifically, the axial thickness ta of the outer ring 96 is desirably between about 0.4 mm and about 1.0 mm. Without wishing to limit the invention to any particular theory of operation, it is believed that a ring having an axial thickness in this range will place both the posterior and the anterior zonules of the eye under tension. Thus, both sets of zonules work in unison to change the diameter of the capsular bag in response to action of the ciliary muscle, resulting in axial movement of the optic. A thinner ring would not interact as effectively with both sets of zonules, and thus, in all likelihood, would result in less axial movement.


In addition, an outer ring 96 having increased axial thickness will increase the pressure on the sharp corner 99 of the edge surface 97 to increase the barrier effect of the ring against PCO.



FIGS. 7A–7E show another IOL 100 of the present invention having a circular outer capsular bag support ring 102, an inner optic 104, and a movement system comprising a plurality of radially-oriented plate-like intermediate members 106 extending therebetween. Preferably, the optic 104, whether it be bi-convex or otherwise, is circumscribed by a circular rim 105 to which the fixation intermediate members 106 are directly attached. The rim 105 desirably has a constant axial dimension and helps to reduce glare while not increasing incision size.


Movement systems other than that shown may be suitable, such as a more solid interface rather than discrete intermediate members. However, separated intermediate members with voids therebetween and between the optic 104 and support ring 102 are preferred. The support ring 102, inner optic 104, and intermediate members 106 are firmly attached to each other with adhesive or ultrasonic bonding, or preferably formed integrally, i.e., molded or machined as one cohesive (homogeneous) piece of material. The IOL 100 is desirably liquid injection molded from silicone or machined from a hydrophilic material which fabrication process reduces cost and increases quality and/or consistency of the product.



FIG. 7A illustrates the IOL 100 from the posterior side, while FIG. 7B is an anterior view. These two views show the axial position at which the intermediate members 106 attach to the support ring 102. That is, the support ring 102 has an axial dimension and the intermediate members 106 attach to a posterior edge thereof. When implanted, the intermediate members 106 and connected optic 104 are therefore held in a posterior-most position with respect to the support ring 102.


As in the embodiment of FIG. 6, the edge surface of the outer ring 102 is contoured to facilitate implantation within the capsular bag of the patient. More particularly, the support ring 102 has an outer surface that is convexly curved to better mate with the concave inner wall portion of the capsular bag between the anterior and posterior zonules.


With reference to FIGS. 7C and 7E, the intermediate members 106 comprise a radially inner portion 108, a radially outer portion 110, and a hinge 112 therebetween. The inner and outer portions 108, 110 are generally plate-like having larger circumferential dimensions then axial dimensions. The hinge 112 may be formed in a number of ways, and as illustrated comprises a region wherein both the axial and the circumferential thickness are reduced by about 50% with respect to the inner and outer portions 108, 110. The reduced material at the hinge 112 means that it is weaker than the remaining intermediate member and thus will more easily bend at that location. The location of each hinge 112 is desirably the same for all of the fixation intermediate members 106, and preferably is closer to the support ring 102 than to the optic 104. For example, each hinge 112 may be located about 60% of the way from the optic 104 to the support ring 102.



FIG. 7D illustrates the IOL 100 in elevational view wherein the support ring 102 lies substantially in a plane and the optic 104 projects in a posterior direction therefrom by virtue of the shape of the intermediate members 106. Specifically, the intermediate members 106 are bowed slightly in the posterior direction such that the optic 104 will tend to lie against or closely adjacent to the posterior wall of the capsular bag. As explained above, relaxation of the ciliary muscles surrounding the capsular bag either moves the optic 104 in the anterior direction or reduces the posterior bias imparted thereto by the intermediate members 106. As a result, the vitreous humor behind the capsular bag can move the optic 106 forward, or in the anterior direction.


In one exemplary embodiment, the support ring 102 has a diameter of between about 9.0–10.5 mm, and an axial thickness of about 0.7 mm. Furthermore, the support ring 102 has a curvature that mimics the curvature of the natural capsular bag between the anterior and posterior zonules, which curvature is between about 0.3–1.0 mm. As mentioned above, at least one corner edge of the outer ring is left sharp to help prevent cell growth thereon.


Although three radial intermediate members 106 are illustrated 1201 apart, the configuration of the intermediate members 106 may vary. However, two factors that are believed to facilitate axial movement, or accommodation, of the optic 104 are the tripod orientation and presence of the hinges 112. More specifically, inward radial forces from the surrounding ciliary muscle and intermediary zonules are transmitted from the support ring 102 through the intermediate members 106 to the optic 104. Because the intermediate members 106 are oriented so that none is diametrically opposed to another, there are no directly opposing forces and a larger component therefore translates into axial movement of the optic 104.


The intermediate members 106 are plate-like to increase stability of the lens in the eye. That is, the forces imparted by the surrounding ciliary muscle may not be entirely uniform and may exert torsional forces on the lens. Plate-like intermediate members 106 help resist twisting of the lens and thus increase stability. The circumferential thickness, or width, of the intermediate members 106 may be between about 1.5–4.0 mm, and the axial thickness is desirably between about 0.2–0.5 mm.



FIG. 9 shows an alternate embodiment of an IOL 102′ substantially similar to the embodiment of FIGS. 7A-7E, except that the thickness of the hinge portion 112′ is reduced in the axial direction only. That is, the circumferential thickness, or width, of each plate-like intermediate member 106′ is uniform throughout its length. This hinge configuration has been found to be less susceptible to fibrosis than a hinge configuration having reduced thickness in the circumferential direction.


Another alternative IOL 120 of the present invention is seen in FIGS. 8A–8D. As in an earlier embodiment, there are only two intermediate members 122 extending between an oval shaped outer capsular bag support ring 124 and an inner circular optic 126. In the illustrated embodiment, the outer ring 124 comprises a band having a generally rectangular cross-section with a longer axial than radial dimension. Preferably, at least one corner of the outer ring 124 is sharp to prevent epithelial cell growth thereon. The support ring 124, inner optic 126, and intermediate members 122 are firmly attached to each other with adhesive or ultrasonic bonding, or preferably formed integrally, i.e., molded or machined as a cohesive single piece. The IOL 120 is desirably liquid injection molded from silicone or machined from a hydrophilic material which, again, reduces cost and increases quality and/or consistency of the product.


As seen best in FIG. 8D, the oval outer ring 124 has a major axis 121 and a minor axis 123, and the two intermediate members 122 are diametrically opposed across the optic 126 along the major axis 123. In one exemplary embodiment, the support ring 124 has a major diameter of between about 115–135% of the minor diameter.


The intermediate members 122 are plate-like, each having a relatively larger circumferential than axial dimension. In contrast to the IOL 100 of FIGS. 7A–7D, the intermediate members 122 lie in a plane defined by the oval-shaped outer ring 124, and thus the optic 126 is not bowed either way. Furthermore, the intermediate members 122 are joined to the inner surface of the outer ring 124 at approximately the axial midpoint thereof. Therefore, in contrast to the earlier embodiment, the optic 126 is not positioned or biased to favor movement in one direction or the other.


With reference to FIG. 8A, each intermediate member 122 has a hinge 128 therein located closer to the outer ring 124 than to the optic 126. The location of each hinge 128 is desirably the same for all of the intermediate members 122, and preferably is located about 75% or more of the way from the optic 126 to the support ring 124. Empirical determination of hinge 128 location optimizes the design such that less radial and axial compression force is required to axially translate the optic 126, while at the same time the ability of the lens to resist twisting is not adversely affected. In the illustrated embodiment, these hinges 128 are formed by reduced axial thickness portions along each intermediate member 122. For example, curved troughs on both sides of intermediate members 122 as shown may form the hinges. Alternatively, or in addition, the circumferential dimension of each intermediate member 122 may be reduced.


As with the earlier embodiment, the optic 126, whether it be biconvex or otherwise, is recessed from a circular rim 130 to which the intermediate members 122 are directly attached. The rim 130 is slightly tapered downward toward the optic and helps reduce glare on the lens. Desirably, the maximum axial dimension of the rim 130 is greater than the center thickness of the optic 126. Advantageously, a reduced center thickness permits a reduction in incision size.



FIGS. 10A–10C show an alternate embodiment of an IOL 120′ similar to the embodiment of FIGS. 8A-8D, except that the optic 126′ is multifocal, and oval support ring 124′ has a non-uniform cross-sectional area. Specifically, the radial thickness of the support ring 124′ increases from a minimum value tr1, for instance about 0.2 mm, at diametrically opposed locations 125a and 125b along the minor axis 121′, to a maximum value tr2, for instance about 0.6 mm, at diametrically opposed locations along the major axis 123′, where the intermediate members 122′ are secured to the ring 124′. In addition, the axial thickness ta of the ring 124′ is constant throughout the entire circumference of the ring 124′ and has a value greater than the maximum radial thickness tr2.


The circumferential thickness, or width, of each intermediate member 122′ is also non-uniform throughout its length, for instance decreasing in a non-linear fashion from a maximum width where the intermediate member 122′ joins the circular rim 130′ of the optic 126′ to a minimum width at the hinge 128′, and remaining substantially constant between the hinge 128′ and the outer ring 124′. This particular configuration of the oval outer ring 124′ and intermediate members 122′ has been found to be particularly stable, with minimal “flopping”, twisting, or other unwanted movement, of the thinnest portions 125a and 125b of the ring 124′.


A series of tests were run on a prototype IOL in order to evaluate the performance of the IOL under compression. The prototype IOL had the configuration of IOL 120′ shown in FIG. 10 and was formed entirely of a unitary, reinforced cross-linked silicone polymeric material of the type described in Christ U.S. Pat. Nos. 5,236,970, 5,376,694, 5,494,946, 5,661,195, 5,869,549, and 6,277,147. The disclosures of each of these U.S. patents are incorporated in their entirety herein by reference.


During the tests, it was observed that, when the IOL 120′ was compressed an amount in the range of about 0.3 mm to about 1 mm, the image quality in the far zone 132 improved slightly, while the image quality in the near zone (add power=2D), decreased slightly.


Referring to FIGS. 11 and 12, in certain embodiments, an equiconvex optic 204 comprises surfaces 206, 208. Those of skill in the art will recognize that the optic 204 may be characterized by a focal length f (e.g., f1 in FIG. 11 and f2 in FIG. 12) produced as light 210 is refracted by the surfaces 206, 208. It will also be recognized by those of skill in the art that the diopter power D of the equiconvex optic 204 is equal to 1/f, when f is in units of meters. For isotropic compression (e.g., d1, d2 in FIGS. 11 and 12, respectively) or deformation (e.g., deformation of the surfaces 206, 208 illustrated in FIGS. 11 and 12) of the equiconvex optic 204, there exists a relationship between the amount of diametric compression d (i.e. decrease in refractive zone size; for example d1−d2) and the increase in diopter power (for example D2−D1). With an increase in diopter power (e.g., from D1 to D2,) at least some improvement in near vision can be expected. Referring again to FIG. 10, by combining the increased diopter power obtained through deformation of the optic 126′ with that obtained through axial movement, it is believed that enhanced accommodation can be achieved. In other words, a patient's presbyopia can be effectively reduced. Still better accommodation, or further reduction of presbyopia, can be obtained from the add power in the near zone 134 of a multifocal optic 126′, or from the maximum add power of an aspheric optic.


Although the aforementioned tests were performed on an IOL 120′ formed of a reinforced cross-linked silicone polymeric material, the principles of the invention will apply equally well to accommodating IOLs formed of any ophthalmically acceptable, deformable material or combination of materials. For instance, one or more of the optic 126′, intermediate members 122′, and outer ring 124′ may be formed of an acrylic polymeric material. Particularly useful materials and combinations of materials are disclosed in patent application Ser. No. 10/314,069, filed Dec. 5, 2002.


Furthermore, while each of the accommodation assemblies illustrated herein comprises an outer ring surrounding and spaced from the optic with voids therebetween, and a plurality of intermediate members extending between and connecting the optic and the outer ring, these assemblies are merely exemplary. Other assembly configurations capable of effecting both axial movement and accommodating deformation of the optic are also included within the scope of the invention. For instance, accommodation and/or force transfer assemblies of the type shown in the aforementioned co-pending, commonly assigned U.S. patent application Ser. Nos. 09/656,661, 09/657,251, and 09/657,325, may also be suitable.


While the present invention has been described with respect to various specific examples and embodiments, it is to be understood that the invention is not limited thereto and that it can be variously practiced within the scope of the following claims.

Claims
  • 1. An intraocular lens for insertion into an eye, comprising: a unitary, deformable multifocal optic including a first zone having a baseline power for distance vision correction and a second zone having an add power; anda continuous outer ring surrounding the optic and spaced therefrom, the continuous outer ring configured for implantation within a capsular bag of an eye; anda force transfer assembly comprising a plurality of intermediate members extending between and connecting the optic and the outer ring;wherein the force transfer assembly is coupled to the optic and structured to cooperate with the eye to effect deformation of the optic so as to change the power of at least one of the first and second zones.
  • 2. The intraocular lens according to claim 1, wherein the force transfer assembly is structured to change the curvature of at least one of the zones in response to a compressive force exerted by the eye.
  • 3. The intraocular lens according to claim 2, wherein the force transfer assembly is structured to increase the curvature of at least one of the zones in response to a compressive force exerted by the eye.
  • 4. The intraocular lens according to claim 1, wherein the force transfer assembly is structured to cooperate with the eye to effect deformation of the first zone so as to increase the baseline power.
  • 5. The intraocular lens according to claim 1, wherein the force transfer assembly is further structured to axially move the optic in response to an action of the eye, wherein the axial movement of the optic combines with the increased add power obtained through the deformation to provide enhanced accommodation relative to the deformation alone.
  • 6. An intraocular lens for insertion into a capsular bag of an eye, comprising: a deformable optic having a periphery and centered about an optical axis, the optic adapted to focus light toward a retina of an eye; andan accommodation assembly coupled to the optic, comprising: an outer ring surrounding the optic and spaced therefrom, the outer ring configured for implantation within a capsular bag of an eye; andat least three intermediate members extending between and connecting the optic and the outer ring;wherein each intermediate member of the at least three intermediate members comprises a hinge.
  • 7. The intraocular lens according to claim 6, wherein each hinge is located closer to the outer ring than to the optic.
  • 8. An intraocular lens for insertion into a capsular bag of an eye, comprising: a deformable optic having a periphery and centered about an optical axis, the optic adapted to focus light toward a retina of an eye; andan accommodation assembly coupled to the optic, comprising: an outer ring surrounding the optic and spaced therefrom, the outer ring configured for implantation within a capsular bag of an eye; andat least three intermediate members extending between and connecting the optic and the outer ring;the deformable optic has a baseline power for distance vision correction and a maximum add power that is reduced relative to a power for full near vision correction; andthe accommodation assembly is structured to cooperate with the eye to effect deformation of the optic so as to increase the maximum add power.
  • 9. The intraocular lens according to claim 8, wherein the optic has progressive vision powers that vary from the baseline power to the maximum add power.
  • 10. The intraocular lens according to claim 9, wherein the accommodation assembly is structured to deform the optic so as to increase the maximum add power in response to compressive forces exerted by the eye.
  • 11. The intraocular lens according to claim 10, wherein the accommodation assembly is further structured to cooperate with the eye to axially move wherein the axial movement of the optic combines with the maximum add power obtained through deformation to provide enhanced accommodation relative to the deformation alone.
  • 12. An intraocular for insertion into a capsular bag of an eye, comprising: a deformable optic having a periphery and centered about an optical axis, the optic adapted to focus light toward a retina of an eye; andan accommodation assembly coupled to the optic, comprising: an outer ring surrounding the optic and spaced therefrom, the outer ring configured for implantation within a capsular bag of an eye; andat least three intermediate members extending between and connecting the optic and the outer ring;wherein the optic is a multifocal optic having a first zone configured to provide distance vision correction and a second zone having an add power that is reduced relative to a power for full near power correction, the combined axial movement, deformation, and add power is effective to provide enhanced accommodation relative to the axial movement and the deformation without the add power.
  • 13. An intraocular for insertion into a capsular bag of an eye, comprising: a deformable optic having a periphery and centered about an optical axis, the optic adapted to focus light toward a retina of an eye; andan accommodation assembly coupled to the optic, comprising: an outer ring surrounding the optic and spaced therefrom, the outer ring configured for implantation within a capsular bag of an eye; andat least three intermediate members extending between and connecting the optic and the outer ring;wherein the optic is an aspheric optic.
  • 14. The intraocular lens of claim 13, wherein the aspheric optic has progressive correction powers that vary from a baseline power for distance vision correction to an add power.
  • 15. The intraocular lens of claim 14, wherein the add power that is reduced relative to a power for full near vision correction.
  • 16. An intraocular lens for insertion into a capsular bag of an eye, comprising: a deformable optic having a periphery and centered about an optical axis, the optic adapted to focus light toward a retina of an eye; andan accommodation assembly, comprising: a continuous outer ring surrounding the optic and spaced therefrom, the outer ring configured for implantation within a capsular bag of the eye; anda plurality of intermediate members extending between and connecting the optic and the outer ring;wherein the accommodation assembly is structured to cooperate with the eye to effect deformation of the optic;wherein each intermediate member of the plurality of intermediate members comprises a hinge.
  • 17. The intraocular lens according to claim 16, wherein each hinge is located closer to the outer ring than to the optic.
  • 18. An intraocular lens for insertion into a capsular bag of an eye, comprising: a deformable optic having a periphery and centered about an optical axis, the optic adapted to focus light toward a retina of an eye; andan accommodation assembly, comprising: a continuous outer ring surrounding the optic and spaced therefrom, the outer ring configured for implantation within a capsular bag of the eye; anda plurality of intermediate members extending between and connecting the optic and the outer ring;wherein the accommodation assembly is structured to cooperate with the eye to effect deformation of the optic;the deformable optic has a baseline power for distance vision correction and a maximum add power that is reduced relative to a power for full near vision correction; andthe accommodation assembly is structured to cooperate with the eye to effect deformation of the optic so as to increase the maximum add power.
  • 19. The intraocular lens according to claim 18, wherein the optic has progressive vision powers that vary from the baseline power to the maximum add power.
  • 20. The intraocular lens according to claim 18, wherein the accommodation assembly is structured to deform the optic so as to increase the maximum add power in response to compressive forces exerted by the eye.
  • 21. The intraocular lens according to claim 20, wherein the accommodation assembly is further structured to cooperate with the eye to axially move wherein the axial movement of the optic combines with the maximum add power obtained through deformation to provide enhanced accommodation relative to the deformation alone.
  • 22. An intraocular lens for insertion into a capsular bag of an eye, comprising: a deformable optic having a periphery and centered about an optical axis, the optic adapted to focus light toward a retina of an eye; andan accommodation assembly, comprising: a continuous outer ring surrounding the optic and spaced therefrom, the outer ring configured for implantation within a capsular bag of the eye; anda plurality of intermediate members extending between and connecting the optic and the outer ring;wherein the accommodation assembly is structured to cooperate with the eye to effect deformation of the optic;wherein the optic is a multifocal optic having a first zone configured to provide distance vision correction and a second zone having an add power that is reduced relative to a power for full near power correction, the combined axial movement, deformation, and add power is effective to provide enhanced accommodation relative to the axial movement and the deformation without the add power.
  • 23. An intraocular lens for insertion into a capsular bag of an eye, comprising: a deformable optic having a periphery and centered about an optical axis, the optic adapted to focus light toward a retina of an eye; andan accommodation assembly, comprising: a continuous outer ring surrounding the optic and spaced therefrom, the outer ring configured for implantation within a capsular bag of the eye; anda plurality of intermediate members extending between and connecting the optic and the outer ring;wherein the accommodation assembly is structured to cooperate with the eye to effect deformation of the optic;wherein the optic is an aspheric optic.
  • 24. The intraocular lens of claim 23, wherein the aspheric optic has progressive correction powers that vary from a baseline power for distance vision correction to an add power.
  • 25. The intraocular lens of claim 24, wherein the add power that is reduced relative to a power for full near vision correction.
  • 26. An intraocular lens for insertion into a capsular bag of an eye, comprising: a deformable optic having a periphery and centered about an optical axis, the optic adapted to focus light toward a retina of an eye; andan accommodation assembly, comprising: a continuous outer ring surrounding the optic and spaced therefrom, the outer ring configured for implantation within a capsular bag of the eye; anda plurality of intermediate members extending between and connecting the optic and the outer ring;wherein the accommodation assembly is structured to cooperate with the eye to effect deformation of the optic;wherein the plurality of intermediate members are oriented so that none of the intermediate members is diametrically opposed to any of the remaining intermediate members.
Parent Case Info

This application is a Continuation-In-Part application of U.S. patent application Ser. No. 10/341,701, filed Jan. 14, 2003 now U.S. Pat. No. 7,025,783, which claimed the benefit of provisional application Ser. No. 60/348,705, filed Jan. 14, 2002, and provisional application Ser. No. 60/372,309, filed Apr. 12, 2002. The disclosures of the aforementioned application and each of the provisional applications are incorporated in their entireties herein by reference.

US Referenced Citations (258)
Number Name Date Kind
1483509 Bugbee Feb 1924 A
2129305 Feinbloom Sep 1938 A
2274142 Houchin Feb 1942 A
2405989 Beach Jun 1946 A
2511517 Spiegel Jun 1950 A
2834023 Lieb May 1958 A
3004470 Ruhle Oct 1961 A
3031927 Wesley May 1962 A
3034403 Neefe May 1962 A
RE25286 DeCarle Nov 1962 E
3210894 Bentley et al. Oct 1965 A
3227507 Feinbloom Jan 1966 A
3339997 Wesley Sep 1967 A
3420006 Barnett Jan 1969 A
3431327 Tsuetaki Mar 1969 A
3482906 Volk Dec 1969 A
3542461 Girard et al. Nov 1970 A
3673616 Federov et al. Jul 1972 A
3693301 Lemaltre Sep 1972 A
3711870 Deitrick Jan 1973 A
3718870 Keller Feb 1973 A
3794414 Wesley Feb 1974 A
3866249 Flom Feb 1975 A
3906551 Otter Sep 1975 A
3913148 Potthast Oct 1975 A
3922728 Krasnov Dec 1975 A
3925825 Richards et al. Dec 1975 A
3932148 Krewalk, Sr. Jan 1976 A
4010496 Neefe Mar 1977 A
4014049 Richards et al. Mar 1977 A
4041552 Ganias Aug 1977 A
4053953 Flom et al. Oct 1977 A
4055378 Feneberg et al. Oct 1977 A
4056855 Kelman Nov 1977 A
4062629 Winthrop Dec 1977 A
4073579 Deeg et al. Feb 1978 A
4074368 Levy, Jr. et al. Feb 1978 A
4087866 Choyce et al. May 1978 A
4110848 Jensen Sep 1978 A
4159546 Shearing Jul 1979 A
4162122 Cohen Jul 1979 A
4195919 Shelton Apr 1980 A
4199231 Evans Apr 1980 A
4210391 Cohen Jul 1980 A
4240719 Gullino et al. Dec 1980 A
4244060 Hoffer Jan 1981 A
4244597 Dandl Jan 1981 A
4251887 Anis Feb 1981 A
4253199 Banko Mar 1981 A
4254509 Tennant Mar 1981 A
4261065 Tennant Apr 1981 A
4274717 Davenport Jun 1981 A
4285072 Morcher et al. Aug 1981 A
4298994 Clayman Nov 1981 A
4307945 Kitchen et al. Dec 1981 A
4315336 Poler Feb 1982 A
4315673 Guilino et al. Feb 1982 A
4316293 Bayers Feb 1982 A
4338005 Cohen Jul 1982 A
4340283 Cohen Jul 1982 A
4340979 Kelman Jul 1982 A
4361913 Streck Dec 1982 A
4370760 Kelman Feb 1983 A
4373218 Schachar Feb 1983 A
4377329 Poler Mar 1983 A
4377873 Reichert, Jr. Mar 1983 A
4402579 Poler Sep 1983 A
4404694 Kelman Sep 1983 A
4409691 Levy Oct 1983 A
4418991 Breger Dec 1983 A
4424597 Schlegel Jan 1984 A
4442553 Hessburg Apr 1984 A
4463458 Seidner Aug 1984 A
4476591 Arnott Oct 1984 A
4504981 Walman Mar 1985 A
4504982 Burk Mar 1985 A
4512040 McClure Apr 1985 A
4551864 Akhavi Nov 1985 A
4560383 Leiske Dec 1985 A
4562600 Ginsberg et al. Jan 1986 A
4573775 Bayshore Mar 1986 A
4573998 Mazzocco Mar 1986 A
4575878 Dubroff Mar 1986 A
4580882 Nuchman et al. Apr 1986 A
4581033 Callahan Apr 1986 A
4596578 Kelman Jun 1986 A
4615701 Woods Oct 1986 A
4617023 Peyman Oct 1986 A
4618228 Baron et al. Oct 1986 A
4618229 Jacobstein et al. Oct 1986 A
4629460 Dyer Dec 1986 A
4636049 Blaker Jan 1987 A
4636211 Nielsen et al. Jan 1987 A
4637697 Freeman Jan 1987 A
4641934 Freeman Feb 1987 A
4661108 Grendahl et al. Apr 1987 A
4664666 Barrett May 1987 A
4676792 Praeger Jun 1987 A
4687484 Kaplan Aug 1987 A
4693572 Tsnetaki et al. Sep 1987 A
4693716 Mackool Sep 1987 A
RE32525 Pannu Oct 1987 E
4702244 Mazzocco Oct 1987 A
4704016 DeCarle Nov 1987 A
4710194 Kelman Dec 1987 A
4720286 Bailey et al. Jan 1988 A
4725278 Shearing Feb 1988 A
4737322 Bruns et al. Apr 1988 A
4752123 Blaker Jun 1988 A
4759762 Grendahl Jul 1988 A
4769033 Nordan Sep 1988 A
4769035 Kelman Sep 1988 A
4787903 Grendahl Nov 1988 A
4790847 Woods Dec 1988 A
4813955 Achatz et al. Mar 1989 A
4816032 Hetland Mar 1989 A
4830481 Futhey et al. May 1989 A
4840627 Blumenthal Jun 1989 A
4842601 Smith Jun 1989 A
4878911 Anis Nov 1989 A
4881804 Cohen Nov 1989 A
4888012 Horn et al. Dec 1989 A
4888015 Domino Dec 1989 A
4888016 Langerman Dec 1989 A
4890912 Visser Jan 1990 A
4890913 DeCarle Jan 1990 A
4892543 Turley Jan 1990 A
4898461 Portney Feb 1990 A
4906246 Grendahl Mar 1990 A
4917681 Nordan Apr 1990 A
4919663 Grendahl Apr 1990 A
4921496 Grendahl May 1990 A
4923296 Erickson May 1990 A
4932966 Christie et al. Jun 1990 A
4932968 Caldwell et al. Jun 1990 A
4938583 Miller Jul 1990 A
4955902 Kelman Sep 1990 A
4976534 Milge et al. Dec 1990 A
4976732 Vorosmarthy Dec 1990 A
4990159 Kraff Feb 1991 A
4994082 Richards et al. Feb 1991 A
4994083 Sulc et al. Feb 1991 A
5000559 Takahashi et al. Mar 1991 A
5002382 Seidner Mar 1991 A
5019098 Mercier May 1991 A
5019099 Nordan May 1991 A
5047051 Cumming Sep 1991 A
5047052 Dubroff Sep 1991 A
5071432 Baikoff Dec 1991 A
5089024 Christie et al. Feb 1992 A
5096285 Silberman Mar 1992 A
5112351 Christie et al. May 1992 A
5129718 Futhey et al. Jul 1992 A
5147397 Christ et al. Sep 1992 A
5152789 Willis Oct 1992 A
5158572 Nielsen Oct 1992 A
5166711 Portney Nov 1992 A
5166712 Portney Nov 1992 A
5171266 Wiley et al. Dec 1992 A
5173723 Volk Dec 1992 A
5192317 Kalb Mar 1993 A
5192318 Schneider Mar 1993 A
5201762 Hauber Apr 1993 A
5225858 Portney Jul 1993 A
5258025 Fedorov et al. Nov 1993 A
5260727 Oksman et al. Nov 1993 A
5270744 Portney Dec 1993 A
5275623 Sarfarazi Jan 1994 A
5354335 Lipshitz et al. Oct 1994 A
RE34998 Langerman Jul 1995 E
5443506 Garabet Aug 1995 A
5476514 Cumming Dec 1995 A
5480428 Fedorov et al. Jan 1996 A
5489302 Skottun Feb 1996 A
5496366 Cumming Mar 1996 A
5521656 Portney May 1996 A
5562731 Cumming Oct 1996 A
5574518 Mercure Nov 1996 A
5578081 McDonald Nov 1996 A
5593436 Langerman Jan 1997 A
5607472 Thompson Mar 1997 A
5628795 Langerman May 1997 A
5628796 Suzuki May 1997 A
5628797 Richer May 1997 A
5652014 Galin et al. Jul 1997 A
5652638 Roffman et al. Jul 1997 A
5657108 Portney Aug 1997 A
5674282 Cumming Oct 1997 A
5682223 Menezes et al. Oct 1997 A
5684560 Roffman et al. Nov 1997 A
5766244 Binder Jun 1998 A
5769890 McDonald Jun 1998 A
5776191 Mazzocco Jul 1998 A
5776192 McDonald Jul 1998 A
5814103 Lipshitz et al. Sep 1998 A
5824074 Koch Oct 1998 A
5843188 McDonald Dec 1998 A
5847802 Meneles et al. Dec 1998 A
5876442 Lipshitz et al. Mar 1999 A
5898473 Seidner et al. Apr 1999 A
5968094 Werblin et al. Oct 1999 A
6013101 Israel Jan 2000 A
6051024 Cumming Apr 2000 A
6096078 McDonald Aug 2000 A
6110202 Barraquer et al. Aug 2000 A
6117171 Skottun Sep 2000 A
6136026 Israel Oct 2000 A
6152958 Nordan Nov 2000 A
6176878 Gwon et al. Jan 2001 B1
6197058 Portney Mar 2001 B1
6200342 Tassignon Mar 2001 B1
6217612 Woods Apr 2001 B1
6231603 Lang et al. May 2001 B1
6299641 Woods Oct 2001 B1
6302911 Hanna Oct 2001 B1
6322589 Cumming Nov 2001 B1
6406494 Laguette et al. Jun 2002 B1
6443985 Woods Sep 2002 B1
6485516 Boehm Nov 2002 B1
6488708 Sarfarazi Dec 2002 B1
6503276 Lang et al. Jan 2003 B1
6524340 Israel Feb 2003 B1
6551354 Ghazizadeh et al. Apr 2003 B1
6554859 Lang et al. Apr 2003 B1
6558420 Green May 2003 B1
6592621 Domino Jul 2003 B1
6599317 Weinschenk, III et al. Jul 2003 B1
6616691 Tran Sep 2003 B1
6616692 Glick et al. Sep 2003 B1
6638305 Laguette Oct 2003 B1
6638306 Cumming Oct 2003 B1
6645246 Weinschenk, III et al. Nov 2003 B1
6660035 Lang et al. Dec 2003 B1
6749633 Lorenzo et al. Jun 2004 B1
6749634 Hanna Jun 2004 B1
6855164 Glazier Feb 2005 B1
7018409 Glick et al. Mar 2006 B1
7025783 Brady et al. Apr 2006 B1
20020111678 Zadno-Azizi et al. Aug 2002 A1
20020116058 Zadno-Azizi et al. Aug 2002 A1
20020120329 Lang et al. Aug 2002 A1
20020188351 Laguette Dec 2002 A1
20030130732 Sarfarazi Jul 2003 A1
20030135272 Brady et al. Jul 2003 A1
20030149480 Shadduck Aug 2003 A1
20030187505 Liao Oct 2003 A1
20030204254 Peng et al. Oct 2003 A1
20030204255 Peng et al. Oct 2003 A1
20040054408 Glick et al. Mar 2004 A1
20040082993 Woods Apr 2004 A1
20040082994 Woods et al. Apr 2004 A1
20040111153 Woods et al. Jun 2004 A1
20040158322 Shen Aug 2004 A1
20040181279 Nun Sep 2004 A1
20040215340 Mebner et al. Oct 2004 A1
20050085907 Hanna Apr 2005 A1
20050131535 Woods Jun 2005 A1
20050137703 Chen Jun 2005 A1
Foreign Referenced Citations (54)
Number Date Country
3225789 Oct 1989 AU
681687 May 1993 CH
2702117 Jul 1978 DE
2702117 Jul 1978 DE
3246306 Jun 1984 DE
3246306 Jun 1984 DE
4038088 Jun 1992 DE
4038088 Jun 1995 DE
0064812 Nov 1982 EP
0246216 Nov 1987 EP
0329981 Aug 1989 EP
0337390 Oct 1989 EP
0342895 Nov 1989 EP
0351471 Jan 1990 EP
0 356 050 Feb 1990 EP
0488835 Jun 1992 EP
0507292 Oct 1992 EP
0566170 Oct 1993 EP
0601845 Jun 1994 EP
0691109 Jan 1996 EP
0897702 Feb 1999 EP
0766540 Apr 1999 EP
2058391 Apr 1981 GB
2124500 Feb 1984 GB
2129155 May 1984 GB
2146791 Apr 1985 GB
2192291 Jan 1988 GB
2215076 Sep 1989 GB
8603961 Jul 1986 WO
8700299 Jan 1987 WO
8707496 Dec 1987 WO
8902251 Mar 1989 WO
8911672 Nov 1989 WO
9000889 Feb 1990 WO
9305733 Apr 1993 WO
9416648 Aug 1994 WO
9503783 Feb 1995 WO
9610968 Apr 1996 WO
9615734 May 1996 WO
9625126 Aug 1996 WO
9712272 Apr 1997 WO
9727825 Aug 1997 WO
9743984 Nov 1997 WO
9856315 Dec 1998 WO
0066039 Nov 2000 WO
WO 0119288 Mar 2001 WO
0134066 May 2001 WO
0134067 May 2001 WO
WO 0219949 Mar 2002 WO
WO 03059208 Jul 2003 WO
WO 05018504 Jul 2004 WO
05018504 Mar 2005 WO
888414 Oct 1988 ZA
888414 Nov 1988 ZA
Related Publications (1)
Number Date Country
20040127984 A1 Jul 2004 US
Provisional Applications (2)
Number Date Country
60372309 Apr 2002 US
60348705 Jan 2002 US
Continuation in Parts (1)
Number Date Country
Parent 10341701 Jan 2003 US
Child 10661410 US